AFX logo

Carl Zeiss Meditec AG Stock Price

XTRA:AFX Community·€4.0b Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 45 Fair Values set on narratives written by author

AFX Share Price Performance

€45.24
-23.01 (-33.71%)
34.4% undervalued intrinsic discount
€69.00
Fair Value
€45.24
-23.01 (-33.71%)
39.6% undervalued intrinsic discount
€74.88
Fair Value
Price €45.24
AnalystHighTarget €74.88
AnalystConsensusTarget €53.61
AnalystLowTarget €39.53

AFX Community Narratives

AnalystHighTarget·Updated
Fair Value €69 34.4% undervalued intrinsic discount

Digital And AI Advances Will Expand Global Eye Care Markets

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AnalystConsensusTarget·Updated
Fair Value €53.61 15.6% undervalued intrinsic discount

VISUMAX 800 Approval In China Will Strengthen Future Market Position

1users have liked this narrative
0users have commented on this narrative
24users have followed this narrative
AnalystLowTarget·Updated
Fair Value €36.93 22.5% overvalued intrinsic discount

Regulatory Uncertainty And Trade Tensions Will Depress Margins

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative

Recent AFX News & Updates

Carl Zeiss Meditec AG's (ETR:AFX) Share Price Matching Investor Opinion

Aug 29
Carl Zeiss Meditec AG's (ETR:AFX) Share Price Matching Investor Opinion

Carl Zeiss Meditec AG Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Aug 10
Carl Zeiss Meditec AG Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Carl Zeiss Meditec (ETR:AFX) Could Be Struggling To Allocate Capital

Jul 01
Carl Zeiss Meditec (ETR:AFX) Could Be Struggling To Allocate Capital

Why Carl Zeiss Meditec's (ETR:AFX) Shaky Earnings Are Just The Beginning Of Its Problems

May 19
Why Carl Zeiss Meditec's (ETR:AFX) Shaky Earnings Are Just The Beginning Of Its Problems

Is It Time To Consider Buying Carl Zeiss Meditec AG (ETR:AFX)?

May 16
Is It Time To Consider Buying Carl Zeiss Meditec AG (ETR:AFX)?

Carl Zeiss Meditec AG Key Details

€2.2b

Revenue

€1.0b

Cost of Revenue

€1.1b

Gross Profit

€983.4m

Other Expenses

€150.1m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
Dec 11, 2025
Earnings per share (EPS)
1.72
Gross Margin
52.00%
Net Profit Margin
6.89%
Debt/Equity Ratio
28.5%

Carl Zeiss Meditec AG Competitors

 
 
 
 
 
 
 
 
 
 
 
 

Snowflake Analysis

Excellent balance sheet and good value.

1 Risk
2 Rewards

About AFX

Founded
1846
Employees
5713
CEO
Maximilian Foerst
WebsiteView website
www.zeiss.com/meditec-ag/de/investor-relations.html?vaURL=www.zeiss.de/meditec-ag/ir

Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, such as ametropia (refraction), cataracts, glaucoma, and renital disorders. This segment also provides devices for general ophthalmological examination and care, including slit lamps, refractometers, tonometers, optical coherence tomography devices, and fundus cameras; and devices for functional diagnostics, as well as digital products for storage, evaluation, and sharing of clinical data. In addition, this segment offers surgical ophthalmology products comprising surgical microscopes, biometers, phacoemulsification, and vitrectomy devices; intraocular lenses for cataract patients; and systems and consumables for laser eye surgery. The Microsurgery segment provides products and solutions for invasive surgical treatments; and solutions in the area of ear, nose and throat, plastic and reconstructive, neuro, dental, and spinal surgeries. It serves physicians in various fields and hospitals. The company was founded in 1846 and is headquartered in Jena, Germany. Carl Zeiss Meditec AG is a subsidiary of Carl Zeiss AG.

Market Insight

Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading

German Market Performance

  • 7 Days: 2.6%
  • 3 Months: -0.3%
  • 1 Year: 14.7%
  • Year to Date: 13.3%
The market has climbed by 2.6% over the past week, with every sector up and the Industrials sector leading the way. The market is up 15% over the last 12 months. Earnings are forecast to grow by 17% annually. Market details ›